Metabolic reprogramming and mitochondrial dysfunction have been reported in pancreatic cancer, and by enhancing the nucleotide biosynthesis, the frequently mutated KRAS gene stimulates cancer cell proliferation [42,43,44,45]. This evidence concerns the gene KRAS and cancer.